DENVER--(BUSINESS WIRE)--Feb. 22, 2018--
BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest
independent national provider of infusion and home care management
solutions, today announced that the Company will issue its financial
results press release for the fourth quarter and full year ended
December 31, 2017 on Thursday, March 8, 2018 before the opening of the
U.S. financial markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and Stephen
Deitsch, Senior Vice President, Chief Financial Officer and Treasurer,
will host a conference call as follows:
The online replay will be available within two hours of the call’s
completion in the Investor Relations section of BioScrip’s web site at: www.bioscrip.com.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent national provider of infusion
and home care management solutions, with approximately 2,200 teammates
and nearly 80 service locations across the U.S. BioScrip partners with
physicians, hospital systems, payors, pharmaceutical manufacturers and
skilled nursing facilities to provide patients access to post-acute care
services. BioScrip operates with a commitment to bring customer-focused
pharmacy and related healthcare infusion therapy services into the home
or alternate-site setting. By collaborating with the full spectrum of
healthcare professionals and the patient, BioScrip provides
cost-effective care that is driven by clinical excellence, customer
service, and values that promote positive outcomes and an enhanced
quality of life for those it serves.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180222005481/en/
Source: BioScrip, Inc.
Chief Financial Officer & Treasurer
Kalle Ahl, CFA, 212-836-9614